Fox Chase Cancer Center and the Marvin and Concetta Greenberg Pancreatic Cancer Institute were recently renewed as a Clinical Center of Excellence and named for the first time as an Academic Center of Excellence for Pancreatic Cancer by the National Pancreas Foundation. This distinction places Fox Chase and the Marvin and Concetta Greenberg Pancreatic Cancer Institute among the few selected centers in the nation to hold this distinction.
‘True Multidisciplinary Care’
“The process for this application was rigorous. The foundation needs to see that we have true multidisciplinary care, not just that we have the clinical expertise but the academic backbone as well. Because of the Marvin and Concetta Greenberg Pancreatic Cancer Institute, we were able to highlight and showcase what we’ve done in the space of pancreatic research,” said Sanjay S. Reddy, MD, FACS, Co-Director of the Institute.
History of the Institute
The Marvin and Concetta Greenberg Pancreatic Institute was launched in September 2017. Led by Dr. Reddy, Igor Astsaturov, MD, PhD, and Edna Cukierman, PhD, the Institute has since established the pancreas cancer translational research group and, as a group, now have multiple funded grants in pancreatic cancer. Additionally, the translational research group also has 12 ongoing clinical/institutional review board protocols, with four studies awaiting approval or activation, according to Dr. Reddy.
